RISS 검색 - 국내학술지논문

무료
기관 내 무료
유료

내보내기
내책장담기
한글로보기

정확도순

내림차순

내림차순

10개씩 출력

1
Are current labeling terms suitable for people who are at risk of psychosis?

Kim, Sung-Wan,Polari, Andrea,Melville, Fritha,Moller, Bridget,Kim, Jae-Min,Amminger, Paul,Herrman, Helen,McGorry, Patrick,Nelson, Barnaby Elsevier 2017 SCHIZOPHRENIA RESEARCH Vol.188 No.-
- 원문보기
Abstract Inclusion of ‘attenuated psychosis syndrome (APS)’ in the DSM-5 has been hotly debated because of the concern about stigmatising young patients with a ‘psychosis risk’ label. This study aimed to investigate whether current labeling terms such as ‘at risk mental state’, ‘ultra-high risk’ (UHR) and ‘APS’ are suitable for people who are at risk of psychosis. This study included 105 subjects (55 patients aged 15–25years who used an early interventional service to prevent psychosis and 50 professionals who worked with them). A questionnaire regarding their opinions about the stigma associated with the above labels and the Mental Health Consumers' Experience of Stigma scale were administered. The patients were less likely than the professionals to agree that there was stigma associated with the terms ‘UHR’ and ‘APS’. Significantly more patients with a family history of psychosis and those who had transitioned to psychosis agreed that there was stigma associated with the term ‘UHR’ and/or that this term should be changed. Patients who agreed with the negative attitude items for the three labeling terms and the need to change the terms ‘UHR’ and ‘schizophrenia’ showed significantly higher scores on the Stigma scale. In conclusion, patients at risk of psychosis may experience less stigma related to labels than expected by professionals, suggesting that mental health professionals may not be able to help patients unless they listen to their views on nosological and treatment issues rather than make assumptions. Previous stigmatising experiences may have strengthened the stigma attached to this label.
2
Association Between Vitamin D Insufficiency and Metabolic Syndrome in Patients With Psychotic Disorders

Taeyoung Yoo,Wonsuk Choi,JinHee Hong,JuYeon Lee,JaeMin Kim,IlSeon Shin,SooJin Yang,Paul Amminger,Michael Berk,JinSang Yoon,SungWan Kim 대한신경정신의학회 2018 PSYCHIATRY INVESTIGATION Vol.15 No.4
- 원문보기 2
 KCI
 
 스콜라
Objective-This study examined the association between vitamin D and metabolic syndrome in patients with psychotic disorders. Methods-The study enrolled 302 community-dwelling patients with psychotic disorders. Sociodemographic and clinical characteristics, including blood pressure, physical activity, and dietary habit were gathered. Laboratory examinations included vitamin D, lipid profile, fasting plasma glucose, HbA1c, liver function, and renal function. Vitamin D insufficiency was defined as <20 ng/mL. Clinical characteristics associated with vitamin D insufficiency were identified. Results-Among the 302 participants, 236 patients (78.1%) had a vitamin D insufficiency and 97 (32.1%) had metabolic syndrome. Vitamin D insufficiency was significantly associated with the presence of metabolic syndrome (p=0.006) and hypertension (p=0.017). Significant increases in triglycerides and alanine transaminase were observed in the group with a vitamin D insufficiency (p=0.002 and 0.011, respectively). After adjusting for physical activity and dietary habit scores, vitamin D insufficiency remained significantly associated with metabolic syndrome and hypertension. Conclusion-Vitamin D insufficiency was associated with metabolic syndrome and was particularly associated with high blood pressure, although the nature, direction and implications of this association are unclear.